160 related articles for article (PubMed ID: 23886504)
21. Clinical evaluation of an in-house human immunodeficiency virus (HIV) genotyping assay for the detection of drug resistance mutations in HIV-1 infected patients in Singapore.
Chew KK; Ng KY; Khong WX; Kaur P; Yap JK; Chua A; Tan MT; Koh YL; Thoon KC; Leo YS; Ng OT
Ann Acad Med Singap; 2012 Dec; 41(12):553-8. PubMed ID: 23303111
[TBL] [Abstract][Full Text] [Related]
22. Appearance of Drug Resistance-Associated Mutations in Human Immunodeficiency Virus Type 1 CRF01_AE Integrase Derived from Drug-Naive Thai Patients.
Isarangkura-Na-Ayuthaya P; Kaewnoo W; Auwanit W; de Silva UC; Ikuta K; Sawanpanyalert P; Kameoka M
AIDS Res Hum Retroviruses; 2010 Dec; 26(12):1341-3. PubMed ID: 20836708
[TBL] [Abstract][Full Text] [Related]
23. Rapid identification of human immunodeficiency virus type 1 CRF01_AE and BC recombinants by subtype-specific PCR.
Luo H; Su QJ; Shao YM; Xing H; Chen J; Liu W; Zhang ZY; Zang N; Xiao X; Liang H
J Virol Methods; 2011 Feb; 171(2):339-44. PubMed ID: 21126539
[TBL] [Abstract][Full Text] [Related]
24. Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase.
Quashie PK; Oliviera M; Veres T; Osman N; Han YS; Hassounah S; Lie Y; Huang W; Mesplède T; Wainberg MA
J Virol; 2015 Mar; 89(6):3163-75. PubMed ID: 25552724
[TBL] [Abstract][Full Text] [Related]
26. Molecular epidemiological study of HIV-1 CRF01_AE transmission in Hong Kong.
Chen JH; Wong KH; Li P; Chan KC; Lee MP; Lam HY; Cheng VC; Yuen KY; Yam WC
J Acquir Immune Defic Syndr; 2009 Aug; 51(5):530-5. PubMed ID: 19521252
[TBL] [Abstract][Full Text] [Related]
27. Short communication: analysis of the integrase gene from HIV type 1-positive patients living in a rural area of West Cameroon.
Turriziani O; Montagna C; Falasca F; Bucci M; Russo G; Lichtner M; Sobze MS; Vullo V; Pistello M; Antonelli G
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1729-33. PubMed ID: 22214532
[TBL] [Abstract][Full Text] [Related]
28. Analysis of pol integrase sequences in diverse HIV type 1 strains using a prototype genotyping assay.
Eshleman SH; Hudelson SE; Smith P; Hackett J; Holzmayer V; Swanson P; Devare SG; Marlowe N
AIDS Res Hum Retroviruses; 2009 Mar; 25(3):343-5. PubMed ID: 19327053
[TBL] [Abstract][Full Text] [Related]
29. Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients--impact of HIV subtypes and prior raltegravir experience.
Garrido C; Soriano V; Geretti AM; Zahonero N; Garcia S; Booth C; Gutierrez F; Viciana I; de Mendoza C
Antiviral Res; 2011 Jun; 90(3):164-7. PubMed ID: 21439330
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of primary Enfuvirtide (ENF) resistance-associated mutations in HIV-1-infected patients in Hong Kong.
Leung PH; Chen JH; Wong KH; Chan KC; Lam HY; Cheng VC; Yuen KY; Yam WC
J Clin Virol; 2010 Mar; 47(3):273-5. PubMed ID: 20116329
[TBL] [Abstract][Full Text] [Related]
31. Resistance-Associated Mutations and Polymorphisms among Integrase Inhibitor-Naïve HIV-1 Patients in Kuwait.
Chehadeh W; Albaksami O; John SE; Al-Nakib W
Intervirology; 2017; 60(4):131-137. PubMed ID: 29212076
[TBL] [Abstract][Full Text] [Related]
32. Subtype CRF01_AE dominate the sexually transmitted human immunodeficiency virus type 1 epidemic in Guangxi, China.
Li L; Chen L; Liang S; Liu W; Li T; Liu Y; Li H; Bao Z; Wang X; Li J
J Med Virol; 2013 Mar; 85(3):388-95. PubMed ID: 23341369
[TBL] [Abstract][Full Text] [Related]
33. HIV type 1 integrase polymorphisms in treatment-naive and treatment-experienced HIV type 1-infected patients in Thailand where HIV type 1 subtype A/E predominates.
Phuphuakrat A; Pasomsub E; Kiertiburanakul S; Chantratita W; Sungkanuparph S
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):937-43. PubMed ID: 21970343
[TBL] [Abstract][Full Text] [Related]
34. Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes.
Aitken SC; Kliphuis A; Wallis CL; Chu ML; Fillekes Q; Barth R; Stevens W; Rinke de Wit TF; Schuurman R
J Clin Virol; 2012 May; 54(1):21-5. PubMed ID: 22306272
[TBL] [Abstract][Full Text] [Related]
35. Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.
Zhou Z; Wagar N; DeVos JR; Rottinghaus E; Diallo K; Nguyen DB; Bassey O; Ugbena R; Wadonda-Kabondo N; McConnell MS; Zulu I; Chilima B; Nkengasong J; Yang C
PLoS One; 2011; 6(11):e28184. PubMed ID: 22132237
[TBL] [Abstract][Full Text] [Related]
36. Simple subtyping assay for human immunodeficiency virus type 1 subtypes B, C, CRF01-AE, CRF07-BC, and CRF08-BC.
Wei M; Guan Q; Liang H; Chen J; Chen Z; Hei F; Feng Y; Hong K; Huang H; Xing H; Shao Y
J Clin Microbiol; 2004 Sep; 42(9):4261-7. PubMed ID: 15365021
[TBL] [Abstract][Full Text] [Related]
37. Detection of drug resistance-associated mutations in human immunodeficiency virus type 1 integrase derived from drug-naive individuals in Surabaya, Indonesia.
Kotaki T; Khairunisa SQ; Sukartiningrum SD; Witaningrum AM; Rusli M; Diansyah MN; Arfijanto MV; Rahayu RP; Nasronudin ; Kameoka M
AIDS Res Hum Retroviruses; 2014 May; 30(5):489-92. PubMed ID: 24328535
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia.
Armenia D; Fabeni L; Alteri C; Di Pinto D; Di Carlo D; Bertoli A; Gori C; Carta S; Fedele V; Forbici F; D'Arrigo R; Svicher V; Berno G; Pizzi D; Nicastri E; Sarmati L; Pinnetti C; Ammassari A; D'Offizi G; Latini A; Andreoni M; Antinori A; Ceccherini-Silberstein F; Perno CF; Santoro MM
J Antimicrob Chemother; 2015; 70(6):1865-73. PubMed ID: 25712318
[TBL] [Abstract][Full Text] [Related]
39. Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection.
Garrido C; Geretti AM; Zahonero N; Booth C; Strang A; Soriano V; De Mendoza C
J Antimicrob Chemother; 2010 Feb; 65(2):320-6. PubMed ID: 20007331
[TBL] [Abstract][Full Text] [Related]
40. HIV Type 1 Integrase Natural Polymorphisms in Viral Variants Circulating in FSU Countries.
Lapovok I; Laga V; Kazennova E; Bobkova M
Curr HIV Res; 2017 Nov; 15(5):318-326. PubMed ID: 28814231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
